Debut Plus

₹415.5

▼ -4.41 -1.05%

17 Jul 2026

NSE Listed

Aarti Drugs Ltd. (AARTIDRUGS)

Volume: 2,89,872Avg Vol 1W: 3,39,092Avg Vol 1M: 2,18,489.552W Range:₹318.95₹564.05
NSE BSE www.aartidrugs.com
Key Ratios
Checked 2h ago
Market Cap₹3,832 Cr
Current Price₹415.5
Previous Close₹419.91
High / Low (52w)₹564.05 / ₹318.95
Volume2,89,872
Avg Vol (1W)3,39,092
Avg Vol (1M)2,18,489.5
Stock P/E69.4
Book Value₹169.7
Dividend Yield48%
ROE12.58%
ROA6.92%
Revenue (TTM)₹2,403 Cr
Revenue Growth-5.6%
Profit Margin7.6%
Total Debt₹284 Cr
Shares Outstanding9 Cr
Face Value₹10
EPS (TTM)₹21.36
P/B2.47
Debt / Equity0.44
50 DMA₹381.82
200 DMA₹397.47
Day change-1.05%
Price Chart
₹415.5▼ 19.76% · 1Y
₹545₹32028.4L
2025-07-17
2026-07-16

20-day avg volume: 2.2L shares

Pros
  • Pays a dividend yield of 48.0%.
  • Company is almost debt-free.
Cons
  • Revenue fell 20% YoY.
  • Stock trades at a high P/E of 69.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹555 Cr₹598 Cr₹557 Cr₹677 Cr₹591 Cr₹653 Cr₹602 Cr₹720 Cr
EBITDA₹53 Cr₹55 Cr₹60 Cr₹80 Cr₹60 Cr₹68 Cr₹38 Cr₹79 Cr
Net Profit₹33 Cr₹35 Cr₹37 Cr₹63 Cr₹54 Cr₹45 Cr₹41 Cr₹55 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹1,245 Cr₹1,563 Cr₹1,808 Cr₹2,159 Cr₹2,500 Cr₹2,718 Cr₹2,533 Cr₹2,403 Cr
EBITDA₹159 Cr₹167 Cr₹215 Cr₹392 Cr₹291 Cr₹257 Cr₹269 Cr₹248 Cr
Net Profit₹82 Cr₹90 Cr₹141 Cr₹280 Cr₹205 Cr₹166 Cr₹171 Cr₹168 Cr
EPS34.93815.1730.0922.1217.9718.6518.42
Balance Sheet
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹1,389 Cr₹1,455 Cr₹1,577 Cr₹1,766 Cr₹2,208 Cr₹2,421 Cr₹2,432 Cr₹2,575 Cr
Total Liabilities₹934 Cr₹912 Cr₹924 Cr₹853 Cr₹1,172 Cr₹1,229 Cr₹1,150 Cr₹1,205 Cr
Equity₹455 Cr₹543 Cr₹652 Cr₹913 Cr₹1,036 Cr₹1,193 Cr₹1,282 Cr₹1,369 Cr
Total Debt————————
Cash Flow
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹94 Cr₹173 Cr₹292 Cr₹252 Cr₹154 Cr₹193 Cr₹421 Cr₹300 Cr
Investing₹-74 Cr₹-62 Cr₹-33 Cr₹-72 Cr₹-150 Cr₹-164 Cr₹-224 Cr₹-165 Cr
Financing₹4 Cr₹-80 Cr₹-215 Cr₹-81 Cr₹92 Cr₹17 Cr₹-136 Cr₹-82 Cr
Free Cash Flow₹94 Cr₹173 Cr₹292 Cr₹252 Cr₹154 Cr₹193 Cr₹421 Cr₹300 Cr
Shareholding
Promoter 55.03% Institutions 11.8% Public 33.18%
Efficiency & Working Capital
ROCE11.5%
Interest Coverage6.4
Dividend Payout—
Debtor Days115 d
Inventory Days72 d
Payable Days64 d
Cash Conversion Cycle124 d
Working Capital Days187 d
Shareholding Details

As of 2026-03-31

Promoter55%
FII1.6%
DII10.2%
Institutions11.8%
Public33.2%
Promoter Pledge2.5%
No. of Shareholders1,44,946
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Promoters58.7%58.6%57.5%57.1%55.7%55.6%55.4%55.5%55.2%54.7%55%55%
FIIs2%2.3%2.1%2.6%3%2.5%2.3%2.2%2.3%2.7%2.2%1.6%
DIIs4.7%5.3%5.3%6%7.4%7.8%8.8%9.7%9.9%9.9%10.1%10.2%
Public34.6%33.8%35.2%34.3%34%34%33.6%32.6%32.6%32.7%32.7%33.2%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%2.5%
No. of Shareholders1,62,4091,67,4461,70,4141,57,5471,50,2181,90,2811,76,0061,69,7611,60,2601,52,2521,48,3631,44,946
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Prakash Moreshwar PatilShareholding of Promoter and Promoter Group9.6%87,83,869
Dsp Small Cap FundPublic Shareholding8%73,10,185
Harshit Manilal SavlaShareholding of Promoter and Promoter Group4.7%43,23,269
Rashesh Chandrakant GogriShareholding of Promoter and Promoter Group4.6%42,38,874
Priti Prakash PatilShareholding of Promoter and Promoter Group4.4%40,16,315
Seema Harshit SavlaShareholding of Promoter and Promoter Group3.8%35,02,175
Gogri Finserv Pvt. Ltd.Shareholding of Promoter and Promoter Group3.8%34,63,971
Hetal Gogri GalaShareholding of Promoter and Promoter Group3.1%27,87,240
Anushakti Enterprise Private LimitedShareholding of Promoter and Promoter Group2.6%23,92,696
Alchemie Finserv Pvt. Ltd.Shareholding of Promoter and Promoter Group2.2%20,13,410
Icici Prudential Pharma Healthcare And Diaganostics (p.h.d) FundPublic Shareholding2%18,35,062
Chandrakant Vallabhaji GogriShareholding of Promoter and Promoter Group1.9%17,10,097
Jaya Chandrakant GogriShareholding of Promoter and Promoter Group1.7%15,64,023
Tulip Family Trust (gloire Trusteeship Services Private Limited)Shareholding of Promoter and Promoter Group1.5%13,68,429
Adhish P. PatilShareholding of Promoter and Promoter Group1.3%11,41,079
Bhoomi Harshit SavlaShareholding of Promoter and Promoter Group1.1%9,95,164
Vishwa Harshit SavlaShareholding of Promoter and Promoter Group1%9,39,907
Aashay Rashesh GogriShareholding of Promoter and Promoter Group1%8,75,891
Tulip Family Trust (gloire Trusteeship Services Private Limited)Shareholding of Promoter and Promoter Group0.7%6,74,636
Orchid Family Trust (relacion Trusteeship Services Private Limited)Shareholding of Promoter and Promoter Group0.7%6,71,769
Mirik Rajendra GogriShareholding of Promoter and Promoter Group0.7%6,41,814
Renil Rajendra GogriShareholding of Promoter and Promoter Group0.7%5,97,957
Paridhi Business Trust (saswat Trusteeship Private Limited)Shareholding of Promoter and Promoter Group0.6%5,86,471
Dilesh Roadlines Pvt LtdShareholding of Promoter and Promoter Group0.5%4,88,730
Jigna Hiren ShahShareholding of Promoter and Promoter Group0.5%4,52,597
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Prakash Moreshwar Patil00%2026-03-31
Harshit Manilal Savla00%2026-03-31
Rashesh Chandrakant Gogri00%2026-03-31
Priti Prakash Patil00%2026-03-31
Seema Harshit Savla00%2026-03-31
Hetal Gogri Gala00%2026-03-31
Chandrakant Vallabhaji Gogri00%2026-03-31
Jaya Chandrakant Gogri00%2026-03-31
Adhish P. Patil00%2026-03-31
Bhoomi Harshit Savla00%2026-03-31
Vishwa Harshit Savla00%2026-03-31
Aashay Rashesh Gogri00%2026-03-31
Board of Directors
NameDesignationYear
Prakash M PatilCMD & Executive Director2025
Rashesh C GogriED / MD / Promoter2025
Harshit M SavlaED / Joint MD / Promoter2025
Harit P ShahE D & Wholetime Director2025
Uday M PatilWTD & Executive Director2025
Narendra Jagannath SalviNon Executive Director2025
Ankit Vikram PalejaIndependent Non Exe. Director2025
Bhaskar Narayan ThoratIndependent Non Exe. Director2025
Neha GadaIndependent Non Exe. Director2025
Hasmukh DedhiaIndependent Non Exe. Director2025
Sandeep Madhusudan JoshiIndependent Non Exe. Director2025
Shri Ajit E. VenugopalanIndependent Non Exe. Director2025
Rushikesh V DeoleCompany Sec. & Compli. Officer2025
Chandrakant V. GogriChairman Emeritus2025
Segments — Product
SegmentRevenueShare
Manufacturing of API₹0 Cr—
Segments — Geography
RegionRevenueShare
Out of India₹769 Cr35.4%
India₹1,404 Cr64.6%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹101209191
Corporate Actions
TypeDateValueRemark
dividend2026-02-09₹2 (20%)Interim
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
20255500172193
2025100023
202536000036
Insider / Designated-Person Trades

25 recent disclosure(s)

Prakash Moreshwar PatilAcquisition · 50,000
Seema Harshit SavlaAcquisition · 11,000
Harshit Manilal SavlaAcquisition · 14,000
Renil Rajendra GogriDisposal · 1,64,500
Harit Pragji ShahAcquisition · 25,000
ALCHEMIE FINSERV PRIVATE LIMITEDAcquisition · 53,500
Substantial Acquisitions (SAST)

3 disclosure(s)

Market21/03/2025 · 19,575
Market22/12/2023 - 28/05/2024 · 18,38,118
Buy Back02/01/2024 · —
Company Information
Incorporated1984
ChairmanChandrakant V. Gogri
AuditorGokhale & Sathe
Investor Email[email protected]
🌐 www.aartidrugs.com ↗

📍 Plot No N-198 MIDC Tarapur, Pamtembhi Village Palghar Tal, Thane, Maharashtra, 401506

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Aakash Exploration Ser LimitedAARADHYA DISPOSAL INDUS LimitedAarey Drugs & Pharm Ltd.Aarnav Fashions LimitedAaron Industries LimitedAartech Solonics LimitedAarti Industries Ltd.Aarti Pharmalabs LimitedAarti Surfactants LimitedAarvi Encon LimitedAastha Spintex LimitedAatmaj Healthcare LimitedAll “A” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search